{
    "id": 235,
    "name": "BREAST-CANCER-SIGNALLING-PATHWAYS-MDAMB231-COMPLETE",
    "url-publication": "https://doi.org/10.1371/journal.pone.0298788",
    "url-model": "https://github.com/Ktaoma/BoolSyn",
    "keywords": [
        "source (?)",
        "curated (?)",
        "repaired (?)",
        "multi-valued (?)"
    ],
    "variables": 110,
    "inputs": 7,
    "regulations": 270,
    "notes": "### Modifications\n\nRemoved regulations:\nPG, PG\nNRG1, NRG1\nINS, INS\nES, ES\nEGF, EGF\nDLL_i, DLL_i\nIGF1, IGF1\n\nRegulation:\n\nCYCLIN_D_c, (((TEAD1 | TCF4 | STAT3) & !(GSK3B & (CDKN2A & P21)))) & (EIF4E & MYC & STAT3)\n\nwas updated to:\n\nCYCLIN_D_c, (((STAT3) & !(GSK3B & (CDKN2A & P21)))) & (EIF4E & MYC & STAT3)\n\nas the analysis stated that TEAD1 and TCF4 have no effect on CYCLIN_D_c.\n",
    "bib": "@article{bbm-235,\n\tauthor = {Taoma, Kittisak and Ruengjitchatchawalya, Marasri and Liangruksa, Monrudee and Laomettachit, Teeraphan},\n\tyear = {2024},\n\tdoi = {https://doi.org/10.1371/journal.pone.0298788},\n\ttitle = {Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug synergy},\n\tpublisher = {PLOS ONE}\n}\n\n"
}